Proteasome Inhibition in Alzheimer's Disease
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000009
Summary
Although it is clear that increased oxidative damage occurs in AD-affected brains, the mechanism(s) responsible for increasing oxidative stress is still unknown. Dr. Keller has recently found that the formation of a specialized assembly of enzymes known as the multicatalytic proteasome (MCP) is inhibited in AD brains, and that this inhibition leads to oxidative damage and neuron death. Because the MCP is normally involved in breaking down and recycling proteins, it serves important cellular functions. Dr. Keller is focusing on testing the hypothesis that oxidative stress causes inhibition of the MCP, and that MCP inhibition causes the accumulation of oxidized protein and damaged DNA.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD